Biblio

Author Title [ Type

] Year

Filters: Author is Li, Yimei [Clear All Filters]

Journal Article

Leahy ABarz, Li Y, Talano J-A, Elgarten CW, Seif AE, Wang Y, Johnson B, Monos D, Kadauke S, Olson TS, et al. Unrelated donor α/β T-cell and B-cell-depleted HSCT for the treatment of pediatric acute leukemia. Blood Adv. 2021.

Barsan V, Li Y, Prabhu S, Baggott C, Nguyen K, Pacenta H, Phillips CL, Rossoff J, Stefanski H, Talano J-A, et al. Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns. EClinicalMedicine. 2023;65:102268.

Bona K, Li Y, Winestone LE, Getz KD, Huang Y-S, Fisher BT, Desai AV, Richardson T, Hall M, Naranjo A, et al. Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma. J Natl Cancer Inst. 2020.

Lang S-S, Khanna O, Atkin NJ, Palma JE, Yuan I, Storm PB, Heuer GG, Kennedy B, Waanders AJ, Li Y, et al. Perioperative near-infrared spectroscopy cerebral oxygen saturation in symptomatic pediatric hydrocephalus patients at risk for intracranial hypertension. J Neurosurg Pediatr. 2019:1-7.

Seif AE, Li Y, Monos DS, Heidemann SC, Aplenc R, Barrett DM, Casper JT, Freedman JL, Grupp SA, Margolis DA, et al. Partially CD3-depleted unrelated and haploidentical donor PSCT has favorable GVHD and survival rates in pediatric hematologic malignancy. Biol Blood Marrow Transplant. 2019.

Hill-Kayser CE, Tochner Z, Li Y, Kurtz G, Lustig RA, James P, Balamuth N, Womer R, Mattei P, Grupp S, et al. Outcomes after Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma. Int J Radiat Oncol Biol Phys. 2019.

Li X, Yu Y, Wei R, Li Y, Lv J, Liu Z, Zhang Y. In vitro and in vivo study on angiogenesis of porcine induced pluripotent stem cell-derived endothelial cells. Differentiation. 2021;120:10-18.

Arnold SD, Brazauskas R, He N, Li Y, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, et al. The impact of donor type on outcomes and cost of allogeneic hematopoietic cell transplant for pediatric leukemia: a merged CIBMTR and PHIS analysis: Pediatric acute leukemia transplant risks and utilization. Biol Blood Marrow Transplant. 2020.

Cahen VC, Li Y, Getz KD, Elgarten CW, DiNofia AM, Wilkes JJ, Winestone LE, Huang Y-SV, Miller TP, M Gramatges M, et al. Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment. Pediatr Blood Cancer. 2020:e28315.

Li Y, Song D, Yu Z, Zhang Y, Liu Z, Yan T. Effect and mechanism of hypoxia on differentiation of porcine-induced pluripotent stem cells into vascular endothelial cells. In Vitro Cell Dev Biol Anim. 2023.

Getz KD, Li Y, Alonzo TA, Hall M, Gerbing RB, Sung L, Huang Y-S, Arnold S, Seif AE, Miller TP, et al. Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2015.